Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Vandetanib was the first drug to be approved by FDA (April 2011) for treatment of late-stage (metastatic) medullary thyroid cancer in adult patients who are ineligible for surgery
selective and orally active small molecule agonist of adiponectin receptor (AdipoR)
Imadul Islam
InChi: InChI=1S/C28H19FN2O4/c29-24-9-5-4-8-22(24)26-15-14-21(35-26)17-23-25(16-18-6-2-1-3-7-18)30-31(27(23)32)20-12-10-19(11-13-20)28(33)34/h1-15
12(1):16-26
Miglustat 0307 Vandetanib was the first drugMiglustat is a glucosylceramide synthase inhibitor. Product information CAS Number: 72599 27 0 Molecular Weight: 219. 28 Formula: C10H21NO4 Chemical Name: (2R,3R,4R,5S) 1 butyl 2 (hydroxymethyl)piperidine 3,4,5 triol Smiles: CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO InChiKey: UQRORFVVSGFNRO UTINFBMNSA N InChi: InChI=1S C10H21NO4 c1 2 3 4 11 5 8(13)10(15)9(14)7(11)6 12 h7 10,12 15H,2 6H2,1H3 t7 ,8+,9 ,10 m1 s1 Technical Data Appearance: Solid Power